Who is sponsoring NCT05620875?

NCT05620875 is sponsored by Uppsala University.

What drugs are being tested in NCT05620875?

Interventions in NCT05620875: Cerebral injury markers, Cerebral oximetry index.

What condition does NCT05620875 study?

NCT05620875 studies Cardiac; Arteriosclerosis, Aortic Valve Disease.

Is NCT05620875 still recruiting?

NCT05620875 is currently completed. Last updated 30 May 2025.

Last reviewed 2025-05-30 · How we verify

NCT05620875

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Association Between Delivered Oxygen and Cerebral Impact During the Use of Cardiopulmonary Bypass.

Completed Last updated 30 May 2025

What this trial tests

trial testing Cerebral injury markers in Cardiac; Arteriosclerosis in 106 participants. Completed in 4 January 2025.

Timeline

2 January 2023

Primary endpoint
4 January 2025

4 January 2025

Quick facts

Lead sponsor	Uppsala University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	106
Start date	2 January 2023
Primary completion	4 January 2025
Estimated completion	4 January 2025
Sites	1 location across Sweden

Drugs / interventions tested

Cerebral injury markers
Cerebral oximetry index

Conditions studied

Cardiac; Arteriosclerosis — all drugs for Cardiac; Arteriosclerosis →
Aortic Valve Disease — all drugs for Aortic Valve Disease →

Sponsor

Uppsala University

Who can join

Eligibility, any sex, with Cardiac; Arteriosclerosis or Aortic Valve Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigating the connection between delivered oxygen index and cerebral impact with COx (cerebral oximetry index) och cerebral injury markers during the routine use of cardiopulmonary bypass.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Uppsala University trials

Trials by the same sponsor.

NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05620875 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uppsala University
Last refreshed: 30 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05620875.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing